Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Safety and Efficacy of Belantamab Mafodotin with Pembrolizumab in Patients with Relapsed or Refractory Multiple Myeloma

Attaya Suvannasankha,Nizar Bahlis,Suzanne Trudel,Katja Weisel,Christian Koenecke,Albert Oriol,Peter M. Voorhees,Aranzazu A. Alonso,Natalie S. Callander,Maria-Victoria Mateos,Nishitha Reddy,Shawn Hakim,John Lamacchia,Nashita Patel,Danae Williams,Roxanne. C. Jewell, Xiangdong Zhou,Ira Gupta,Joanna Opalinska,Ajay K. Nooka

Cancer（2024）

Cited 0|Views33

Key words

belantamab mafodotin,pembrolizumab,refractory multiple myeloma,dose-escalation,dose-expansion,benefit-risk profile,safety

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined